Brain ResearchNeurosciencePeer-reviewed journal article
Genome-wide synthetic lethal CRISPR screen identifies FIS1 as a genetic interactor of ALS-linked C9ORF72
Noori Chai, Michael Seamus HaneyiD, Julien CouthouisiD, David W. MorgensiD, Alyssa Benjamin, Kathryn WuiD, James A. OuseyiD, Shirleen Fang, Sarah Finer, Michael Cory BassikiD, Aaron D. GitleriD
Abstract
Mutations in the C9ORF72 gene are the most common cause of amyotrophic lateral sclerosis (ALS). Both toxic gain of function and loss of function pathogenic mechanisms have been proposed. Accruing evidence from mouse knockout studies point to a role for C9ORF72 as a regulator of immune function. To provide further insight into its cellular function, we performed a genome-wide synthetic lethal CRISPR screen in human myeloid cells lacking C9ORF72. We discovered a strong synthetic lethal genetic interaction between C9ORF72 and FIS1, which encodes a mitochondrial membrane protein involved in mitochondrial fission and mitophagy. Mass spectrometry experiments revealed that in C9ORF72 knockout cells, FIS1 strongly bound to a class of immune regulators that activate the receptor for advanced glycation end (RAGE) products and trigger inflammatory cascades. These findings present a novel genetic interactor for C9ORF72 and suggest a compensatory role for FIS1 in suppressing inflammatory signaling in the absence of C9ORF72.
- Citations
- 26
- FWCI
- 2.54
- Field percentile
- top 11%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72-ALS iPSC-derived microglia contributes to neurodegeneration
Poulomi Banerjee, Arpan R. Mehta, … Siddharthan Chandran·Science AdvancesPeer-reviewed·Apr 21, 2023
- C9orf72 ALS-causing mutations lead to nucleoporin Nup107 aggregation and subsequent pathological changes
Saygın Bilican, Yara Nabawi, … David Vı́lchez·bioRxiv·Apr 16, 2025
- Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosis
Lydia M. Castelli, Luisa Cutillo, … Guillaume M. Hautbergue·Molecular NeurodegenerationPeer-reviewed·Aug 10, 2021
- Dysregulated expression of inflammasome and extracellular matrix genes in C9orf72-ALS/FTD microglia
Nisha S. Pulimood, Louise Thiry, … Stefano Stifani·bioRxiv·Feb 13, 2025
- C9orf72-ALS mutation drives mitophagy impairments in iNeurons
James Lee, Sarah M. Granger, … Heather Mortiboys·bioRxiv·Feb 28, 2025
- NEK1 haploinsufficiency worsens DNA damage but not defective ciliogenesis in C9ORF72 patient-derived iPSC-motoneurons
Serena Santangelo, Sabrina Invernizzi, … Antonia Ratti·Human Molecular GeneticsPeer-reviewed·Sep 2, 2024